Abstract
Hypermutation and elevated neoantigen count in glioblastoma occurred in a patient harboring a germline POLE mutation and are associated with a clinical and antitumor immune response to PD-1 blockade.
Cite
CITATION STYLE
APA
Snyder, A., & Wolchok, J. D. (2016). Successful treatment of a patient with glioblastoma and a germline POLE mutation: Where next? Cancer Discovery, 6(11), 1210–1211. https://doi.org/10.1158/2159-8290.CD-16-1056
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free